Skip to main content
Erschienen in: Journal of Mammary Gland Biology and Neoplasia 1/2017

11.01.2017

A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer

verfasst von: Lucía Gargiulo, María May, Ezequiel M. Rivero, Sabrina Copsel, Caroline Lamb, John Lydon, Carlos Davio, Claudia Lanari, Isabel A. Lüthy, Ariana Bruzzone

Erschienen in: Journal of Mammary Gland Biology and Neoplasia | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Understanding the mechanisms that govern normal mammary gland development is crucial to the comprehension of breast cancer etiology. β-adrenergic receptors (β-AR) are targets of endogenous catecholamines such as epinephrine that have gained importance in the context of cancer biology. Differences in β2-AR expression levels may be responsible for the effects of epinephrine on tumor vs non-tumorigenic breast cell lines, the latter expressing higher levels of β2-AR. To study regulation of the breast cell phenotype by β2-AR, we over-expressed β2-AR in MCF-7 breast cancer cells and knocked-down the receptor in non-tumorigenic MCF-10A breast cells. In MCF-10A cells having knocked-down β2-AR, epinephrine increased cell proliferation and migration, similar to the response by tumor cells. In contrast, in MCF-7 cells overexpressing the β2-AR, epinephrine decreased cell proliferation and migration and increased adhesion, mimicking the response of the non-tumorigenic MCF-10A cells, thus underscoring that β2-AR expression level is a key player in cell behavior. β-adrenergic stimulation with isoproterenol induced differentiation of breast cells growing in 3-dimension cell culture, and also the branching of murine mammary epithelium in vivo. Branching induced by isoproterenol was abolished in fulvestrant or tamoxifen-treated mice, demonstrating that the effect of β-adrenergic stimulation on branching is dependent on the estrogen receptor (ER). An ER-independent effect of isoproterenol on lumen architecture was nonetheless found. Isoproterenol significantly increased the expression of ERα, Ephrine-B1 and fibroblast growth factors in the mammary glands of mice, and in MCF-10A cells. In a poorly differentiated murine ductal carcinoma, isoproterenol also decreased tumor growth and induced tumor differentiation. This study highlights that catecholamines, through β-AR activation, seem to be involved in mammary gland development, inducing mature duct formation. Additionally, this differentiating effect could be resourceful in a breast tumor context.
Literatur
1.
Zurück zum Zitat Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia. 2002;7(1):17–38.CrossRefPubMed Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia. 2002;7(1):17–38.CrossRefPubMed
2.
Zurück zum Zitat Zeps N, Bentel JM, Papadimitriou JM, D’Antuono MF, Dawkins HJ. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation. 1998;62(5):221–6.CrossRefPubMed Zeps N, Bentel JM, Papadimitriou JM, D’Antuono MF, Dawkins HJ. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation. 1998;62(5):221–6.CrossRefPubMed
3.
Zurück zum Zitat Zhang X, Martinez D, Koledova Z, Qiao G, Streuli CH, Lu P. FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. Development. 2014;141(17):3352–62.CrossRefPubMedPubMedCentral Zhang X, Martinez D, Koledova Z, Qiao G, Streuli CH, Lu P. FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. Development. 2014;141(17):3352–62.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Brisken C, Ataca D. Endocrine hormones and local signals during the development of the mouse mammary gland. Wiley Interdiscip Rev Dev Biol. 2015;4(3):181–95.CrossRefPubMed Brisken C, Ataca D. Endocrine hormones and local signals during the development of the mouse mammary gland. Wiley Interdiscip Rev Dev Biol. 2015;4(3):181–95.CrossRefPubMed
5.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
6.
Zurück zum Zitat Hasen NS, O’Leary KA, Auger AP, Schuler LA. Social isolation reduces mammary development, tumor incidence, and expression of epigenetic regulators in wild-type and p53-heterozygotic mice. Cancer Prev Res (Phila). 2010;3(5):620–9.CrossRef Hasen NS, O’Leary KA, Auger AP, Schuler LA. Social isolation reduces mammary development, tumor incidence, and expression of epigenetic regulators in wild-type and p53-heterozygotic mice. Cancer Prev Res (Phila). 2010;3(5):620–9.CrossRef
7.
Zurück zum Zitat Boyd AL, Salleh A, Humber B, Yee J, Tomes L, Kerr LR. Neonatal experiences differentially influence mammary gland morphology, estrogen receptor {alpha} protein levels, and carcinogenesis in BALB/c mice. Cancer Prev Res (Phila). 2010;3(11):1398–408.CrossRef Boyd AL, Salleh A, Humber B, Yee J, Tomes L, Kerr LR. Neonatal experiences differentially influence mammary gland morphology, estrogen receptor {alpha} protein levels, and carcinogenesis in BALB/c mice. Cancer Prev Res (Phila). 2010;3(11):1398–408.CrossRef
8.
Zurück zum Zitat Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18(5):1201–6.CrossRefPubMed Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18(5):1201–6.CrossRefPubMed
9.
Zurück zum Zitat Tang J, Li Z, Lu L, Cho CH. Beta-adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. Semin Cancer Biol. 2013;23(6 Pt B):533–42.CrossRefPubMed Tang J, Li Z, Lu L, Cho CH. Beta-adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. Semin Cancer Biol. 2013;23(6 Pt B):533–42.CrossRefPubMed
10.
Zurück zum Zitat Perez PC, Bruzzone A, Sarappa M, Castillo L, Luthy I. Involvement of alpha2- and beta2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation. Br J Pharmacol. 2012;166(2):721–36.CrossRef Perez PC, Bruzzone A, Sarappa M, Castillo L, Luthy I. Involvement of alpha2- and beta2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation. Br J Pharmacol. 2012;166(2):721–36.CrossRef
11.
Zurück zum Zitat Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer ResTreat. 2000;60(2):153–66.CrossRef Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer ResTreat. 2000;60(2):153–66.CrossRef
12.
Zurück zum Zitat Carie AE, Sebti SM. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene. 2007;26(26):3777–88.CrossRefPubMed Carie AE, Sebti SM. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene. 2007;26(26):3777–88.CrossRefPubMed
13.
Zurück zum Zitat Inderwies T, Pfaffl MW, Meyer HH, Blum JW, Bruckmaier RM. Detection and quantification of mRNA expression of alpha- and beta-adrenergic receptor subtypes in the mammary gland of dairy cows. Domest Anim Endocrinol. 2003;24(2):123–35.CrossRefPubMed Inderwies T, Pfaffl MW, Meyer HH, Blum JW, Bruckmaier RM. Detection and quantification of mRNA expression of alpha- and beta-adrenergic receptor subtypes in the mammary gland of dairy cows. Domest Anim Endocrinol. 2003;24(2):123–35.CrossRefPubMed
14.
Zurück zum Zitat Marchetti B, Fortier MA, Poyet P, Follea N, Pelletier G, Labrie F. Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. Endocrinology. 1990;126(1):565–74.CrossRefPubMed Marchetti B, Fortier MA, Poyet P, Follea N, Pelletier G, Labrie F. Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. Endocrinology. 1990;126(1):565–74.CrossRefPubMed
15.
Zurück zum Zitat Wellner RB, He XJ, Marmary Y, Baum BJ. Functional beta-adrenergic receptors in a human mammary cell line (HBL-100). Biochem Pharmacol. 1988;37(15):3035–7.CrossRefPubMed Wellner RB, He XJ, Marmary Y, Baum BJ. Functional beta-adrenergic receptors in a human mammary cell line (HBL-100). Biochem Pharmacol. 1988;37(15):3035–7.CrossRefPubMed
16.
Zurück zum Zitat Bruzzone A, Sauliere A, Finana F, Senard JM, Luthy I, Gales C. Dosage-dependent regulation of cell proliferation and adhesion through dual beta2-adrenergic receptor/cAMP signals. FASEB J. 2014;28(3):1342–54.CrossRefPubMed Bruzzone A, Sauliere A, Finana F, Senard JM, Luthy I, Gales C. Dosage-dependent regulation of cell proliferation and adhesion through dual beta2-adrenergic receptor/cAMP signals. FASEB J. 2014;28(3):1342–54.CrossRefPubMed
17.
Zurück zum Zitat Cakir Y, Plummer III HK, Tithof PK, Schuller HM. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol. 2002;21(1):153–7.PubMed Cakir Y, Plummer III HK, Tithof PK, Schuller HM. Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol. 2002;21(1):153–7.PubMed
18.
Zurück zum Zitat Shi M, Liu D, Duan H, Qian L, Wang L, Niu L, et al. The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat. 2011;125(2):351–62.CrossRefPubMed Shi M, Liu D, Duan H, Qian L, Wang L, Niu L, et al. The beta2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat. 2011;125(2):351–62.CrossRefPubMed
19.
Zurück zum Zitat Re G, Badino P, Girardi C, Di Carlo F. Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res. 1992;26(4):377–84.CrossRefPubMed Re G, Badino P, Girardi C, Di Carlo F. Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res. 1992;26(4):377–84.CrossRefPubMed
20.
Zurück zum Zitat Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.CrossRefPubMedPubMedCentral Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gargiulo L, Copsel S, Rivero EM, Gales C, Senard JM, Luthy IA, et al. Differential beta(2)-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget. 2014;5(20):10058–69.CrossRefPubMedPubMedCentral Gargiulo L, Copsel S, Rivero EM, Gales C, Senard JM, Luthy IA, et al. Differential beta(2)-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget. 2014;5(20):10058–69.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51(5):1409–16.CrossRefPubMed Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973;51(5):1409–16.CrossRefPubMed
23.
Zurück zum Zitat Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5(1):5–23.CrossRefPubMed Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5(1):5–23.CrossRefPubMed
24.
Zurück zum Zitat Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990;50(18):6075–86.PubMed Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990;50(18):6075–86.PubMed
25.
Zurück zum Zitat Prat A, Karginova O, Parker JS, Fan C, He X, Bixby L, et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat. 2013;142(2):237–55.CrossRefPubMedPubMedCentral Prat A, Karginova O, Parker JS, Fan C, He X, Bixby L, et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat. 2013;142(2):237–55.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Vazquez SM, Mladovan AG, Perez C, Bruzzone A, Baldi A, Luthy IA. Human breast cell lines exhibit functional alpha2-adrenoceptors. Cancer Chemother Pharmacol. 2006;58(1):50–61.CrossRefPubMed Vazquez SM, Mladovan AG, Perez C, Bruzzone A, Baldi A, Luthy IA. Human breast cell lines exhibit functional alpha2-adrenoceptors. Cancer Chemother Pharmacol. 2006;58(1):50–61.CrossRefPubMed
27.
Zurück zum Zitat Tubio MR, Fernandez N, Fitzsimons CP, Copsel S, Santiago S, Shayo C, et al. Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form. J Biol Chem. 2010;285(20):14990–8.CrossRefPubMedPubMedCentral Tubio MR, Fernandez N, Fitzsimons CP, Copsel S, Santiago S, Shayo C, et al. Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form. J Biol Chem. 2010;285(20):14990–8.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem. 2002;277(38):35402–10.CrossRefPubMed Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, et al. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem. 2002;277(38):35402–10.CrossRefPubMed
29.
Zurück zum Zitat Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.CrossRefPubMed
30.
Zurück zum Zitat Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995;9(18):2266–78.CrossRefPubMed Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995;9(18):2266–78.CrossRefPubMed
31.
Zurück zum Zitat Sahores A, Luque GM, Wargon V, May M, Molinolo A, Becu-Villalobos D, et al. Novel, low cost, highly effective, handmade steroid pellets for experimental studies. PLoS One. 2013;8(5):e64049.CrossRefPubMedPubMedCentral Sahores A, Luque GM, Wargon V, May M, Molinolo A, Becu-Villalobos D, et al. Novel, low cost, highly effective, handmade steroid pellets for experimental studies. PLoS One. 2013;8(5):e64049.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Vanzulli S, Efeyan A, Benavides F, Helguero LA, Peters G, Shen J, et al. p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis. 2002;23(5):749–58.CrossRefPubMed Vanzulli S, Efeyan A, Benavides F, Helguero LA, Peters G, Shen J, et al. p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis. 2002;23(5):749–58.CrossRefPubMed
33.
34.
Zurück zum Zitat Gouon-Evans V, Pollard JW. Unexpected deposition of brown fat in mammary gland during postnatal development. Mol Endocrinol. 2002;16(11):2618–27.CrossRefPubMed Gouon-Evans V, Pollard JW. Unexpected deposition of brown fat in mammary gland during postnatal development. Mol Endocrinol. 2002;16(11):2618–27.CrossRefPubMed
35.
Zurück zum Zitat Kouros-Mehr H, Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn. 2006;235(12):3404–12.CrossRefPubMedPubMedCentral Kouros-Mehr H, Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn. 2006;235(12):3404–12.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Wargon V, Riggio M, Giulianelli S, Sequeira GR, Rojas P, May M, et al. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters. Int J Cancer. 2015;136(11):2680–92.CrossRefPubMed Wargon V, Riggio M, Giulianelli S, Sequeira GR, Rojas P, May M, et al. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters. Int J Cancer. 2015;136(11):2680–92.CrossRefPubMed
37.
Zurück zum Zitat Silberstein GB, Strickland P, Trumpbour V, Coleman S, Daniel CW. In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc Natl Acad Sci U S A. 1984;81(15):4950–4.CrossRefPubMedPubMedCentral Silberstein GB, Strickland P, Trumpbour V, Coleman S, Daniel CW. In vivo, cAMP stimulates growth and morphogenesis of mouse mammary ducts. Proc Natl Acad Sci U S A. 1984;81(15):4950–4.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Liu S, Lin YC. Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J. 2004;10(6):514–21.CrossRefPubMed Liu S, Lin YC. Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta. Breast J. 2004;10(6):514–21.CrossRefPubMed
40.
Zurück zum Zitat Draoui A, Vandewalle B, Hornez L, Revillion F, Lefebvre J. Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors. Anticancer Res. 1991;11(2):677–80.PubMed Draoui A, Vandewalle B, Hornez L, Revillion F, Lefebvre J. Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors. Anticancer Res. 1991;11(2):677–80.PubMed
41.
Zurück zum Zitat Powe DG, Entschladen F. Targeted therapies: using beta-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol. 2011;8(9):511–2.CrossRefPubMed Powe DG, Entschladen F. Targeted therapies: using beta-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol. 2011;8(9):511–2.CrossRefPubMed
42.
Zurück zum Zitat Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628–38.CrossRefPubMedPubMedCentral Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628–38.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Monami M, Filippi L, Ungar A, Sgrilli F, Antenore A, Dicembrini I, et al. Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. Curr Med Res Opin. 2013;29(4):369–78.CrossRefPubMed Monami M, Filippi L, Ungar A, Sgrilli F, Antenore A, Dicembrini I, et al. Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. Curr Med Res Opin. 2013;29(4):369–78.CrossRefPubMed
44.
Zurück zum Zitat Raimondi S, Botteri E, Munzone E, Cipolla C, Rotmensz N, DeCensi A, et al. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: systematic review and meta-analysis. Int J Cancer. 2016;139(1):212–9.CrossRefPubMed Raimondi S, Botteri E, Munzone E, Cipolla C, Rotmensz N, DeCensi A, et al. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: systematic review and meta-analysis. Int J Cancer. 2016;139(1):212–9.CrossRefPubMed
45.
Zurück zum Zitat van der Westhuizen ET, Breton B, Christopoulos A, Bouvier M. Quantification of ligand bias for clinically relevant beta2-adrenergic receptor ligands: implications for drug taxonomy. Mol Pharmacol. 2014;85(3):492–509.CrossRefPubMed van der Westhuizen ET, Breton B, Christopoulos A, Bouvier M. Quantification of ligand bias for clinically relevant beta2-adrenergic receptor ligands: implications for drug taxonomy. Mol Pharmacol. 2014;85(3):492–509.CrossRefPubMed
46.
Zurück zum Zitat Vrydag W, Michel MC. Tools to study beta3-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol. 2007;374(5–6):385–98.CrossRef Vrydag W, Michel MC. Tools to study beta3-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol. 2007;374(5–6):385–98.CrossRef
47.
Zurück zum Zitat Vandewalle B, Revillion F, Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J Cancer ResClinOncol. 1990;116(3):303–6. Vandewalle B, Revillion F, Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J Cancer ResClinOncol. 1990;116(3):303–6.
48.
Zurück zum Zitat Badino GR, Novelli A, Girardi C, Di Carlo F. Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res. 1996;33(4–5):255–60.PubMed Badino GR, Novelli A, Girardi C, Di Carlo F. Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res. 1996;33(4–5):255–60.PubMed
49.
Zurück zum Zitat Shamir ER, Ewald AJ. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014;15(10):647–64.CrossRefPubMedPubMedCentral Shamir ER, Ewald AJ. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol. 2014;15(10):647–64.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5(9):675–88.CrossRefPubMed Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 2005;5(9):675–88.CrossRefPubMed
51.
Zurück zum Zitat Nedvetsky PI, Kwon SH, Debnath J, Mostov KE. Cyclic AMP regulates formation of mammary epithelial acini in vitro. Mol Biol Cell. 2012;23(15):2973–81.CrossRefPubMedPubMedCentral Nedvetsky PI, Kwon SH, Debnath J, Mostov KE. Cyclic AMP regulates formation of mammary epithelial acini in vitro. Mol Biol Cell. 2012;23(15):2973–81.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000;27:17–37.CrossRef Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000;27:17–37.CrossRef
53.
Zurück zum Zitat Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001;98(20):11755–9.CrossRefPubMedPubMedCentral Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001;98(20):11755–9.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Hermes GL, Delgado B, Tretiakova M, Cavigelli SA, Krausz T, Conzen SD, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A. 2009;106(52):22393–8.CrossRefPubMedPubMedCentral Hermes GL, Delgado B, Tretiakova M, Cavigelli SA, Krausz T, Conzen SD, et al. Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumors. Proc Natl Acad Sci U S A. 2009;106(52):22393–8.CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A. 2006;103(7):2196–201.CrossRefPubMedPubMedCentral Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A. 2006;103(7):2196–201.CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Brisken C, Park S, Vass T, Lydon JP, O’Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A. 1998;95(9):5076–81.CrossRefPubMedPubMedCentral Brisken C, Park S, Vass T, Lydon JP, O’Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A. 1998;95(9):5076–81.CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG, et al. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res. 1999;14(5):776–83.CrossRefPubMed Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG, et al. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res. 1999;14(5):776–83.CrossRefPubMed
58.
Zurück zum Zitat Rajakumar RA, Quinn CO. Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1-binding site. Mol Endocrinol. 1996;10(7):867–78.PubMed Rajakumar RA, Quinn CO. Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1-binding site. Mol Endocrinol. 1996;10(7):867–78.PubMed
59.
Zurück zum Zitat Marchese S, Silva E. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis. PLoS One. 2012;7(10):e45767.CrossRefPubMedPubMedCentral Marchese S, Silva E. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis. PLoS One. 2012;7(10):e45767.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, et al. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol Cell Biol. 2012;32(19):3913–24.CrossRefPubMedPubMedCentral Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, et al. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation. Mol Cell Biol. 2012;32(19):3913–24.CrossRefPubMedPubMedCentral
62.
Metadaten
Titel
A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer
verfasst von
Lucía Gargiulo
María May
Ezequiel M. Rivero
Sabrina Copsel
Caroline Lamb
John Lydon
Carlos Davio
Claudia Lanari
Isabel A. Lüthy
Ariana Bruzzone
Publikationsdatum
11.01.2017
Verlag
Springer US
Erschienen in
Journal of Mammary Gland Biology and Neoplasia / Ausgabe 1/2017
Print ISSN: 1083-3021
Elektronische ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-017-9371-1

Weitere Artikel der Ausgabe 1/2017

Journal of Mammary Gland Biology and Neoplasia 1/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.